Logistics Development Group's Latest Acquisition
Logistics Development Group plc (LDG) has recently entered into a significant agreement to acquire Alliance Pharma. This deal, valued at £337.9 million, marks a major step forward for LDG in the healthcare market.
Terms of the Acquisition
The acquisition will be executed through a court-sanctioned arrangement, with the price set at 62.5p per share of Alliance Pharma. This arrangement allows for a smooth transition and ensures that shareholders are adequately compensated for their investment.
Alliance Pharma Overview
Alliance Pharma is a prominent figure in the healthcare industry, employing a workforce of over 290 people. The company specializes in the marketing and distribution of over-the-counter healthcare products as well as prescription medications. As of the latest reports, the company had net assets amounting to £222.9 million, with an impressive Adjusted EBITDA of £45 million against revenues of £180.7 million for the previous year.
LDG's Position and Strategy
LDG currently holds about 13.2% of Alliance Pharma's issued share capital, which translates to approximately 71,165,281 shares. In alignment with the acquisition plan, LDG will receive an equivalent number of unlisted, non-voting B ordinary shares in Aegros Dominium Limited (Equityco), which is the holding company for Bidco.
Investment Management by DBAY Advisors
The acquisition is facilitated through Bidco, a company specifically formed for this venture. Bidco is under the control of funds managed by DBAY Advisors Limited, which also serves as the investment manager for LDG. This setup indicates that LDG and DBAY are aligned in their strategic approach to this acquisition.
No Cash Funding Required
One of the most noteworthy aspects of this acquisition is that LDG will not need to provide any cash funding. This highlights a careful consideration of financial resources and ensures that LDG’s cash position remains stable. Additionally, LDG plans to look into further shareholder distributions through a tender offer, pending necessary approvals.
A Strategic Move for Growth
This acquisition demonstrates LDG's strategic intent to invest in Alliance Pharma, reflecting a strong belief in the latter's market strength and potential for growth within the healthcare sector. The decision aligns with LDG’s broader investment strategy and commitment to enhancing shareholder value through calculated investments.
Frequently Asked Questions
What is the value of the acquisition deal between LDG and Alliance Pharma?
The acquisition deal is valued at £337.9 million.
How will the acquisition impact LDG's cash position?
LDG will not require any cash funding for the acquisition, ensuring its cash position remains stable.
Who manages the funds for Bidco in the acquisition?
DBAY Advisors Limited acts as the investment manager for LDG and controls the funds managed by Bidco.
What are Alliance Pharma's main business areas?
Alliance Pharma specializes in marketing and distributing over-the-counter healthcare products and prescription medications.
What plans does LDG have regarding shareholder distributions?
LDG intends to proceed with a tender offer for shareholder distribution, pending necessary approval.
